The selective killing effect of adenoviral mediated HSV-tk/GCV suicide gene system controlled by hTERT promoter on bladder cancer cells

被引:0
|
作者
王亚轩
机构
[1] Shijiazhuang 050000
[2] 2nd Hos
[3] Dept Urol
[4] Hebei Med Univ
关键词
D O I
暂无
中图分类号
R737.14 [膀胱肿瘤];
学科分类号
100214 ;
摘要
To investigate the selective killing effect of adenoviral mediated herpes simplex virus-thymidine kinase/ganciclovir (HSV-tk/GCV) suicide gene system controlled by human telomerase reverse transcriptase (hTERT) promoter on bladder cancer cells in vitro.Methods Bladder cancer cell line 253J and human fibroblast cell line MRC-5 were transfected by the recombinant adenovirus of different multiplicities of infection (MOI),and the infection rate was measured by observing the expression of enhanced green fluorescent protein (EGFP) under the fluorescent microscopy.Ad-hTERT-HSV/tk and Ad-CMV-SHV/tk were transduced into 253J and MRC-5,followed by GCV treatment.The relative survival rate of cells in presence of prodrug GCV was measured with MTT method.Results Recombinant adenovirus Ad-hTERT-EGFP could selectively infect 253J cells,with the infection rate associated with the increasing MOI of recombinant adenovirus (P<0.01).When MOI was 1,the infection rate was 8.3%;when MOI was 1000,the infection rate was 100.0%.GCV significantly inhibited the growth of both cell lines (253J and MRC-5) infected with Ad-CMV-HSV/tk and the growth of only 253J infected with Ad-hTERT-HSV/tk (P<0.001).The survival rate of 253J was correlated with the concentration of both the prodrugs and MOI of recombinant adenovirus (P<0.01).When MOI was 1,with 1 μmol/L GCV,the survival rate of 253J was 95.4%;when MOI was 100,with 1000 μmol/L GCV,the survival rate of 253J was 6.1%.Conclusion Recombinant adenovirus vector containing EGFP can report the transfection rate accurately and easily.Adenoviral vector containing hTERT promoter for the HSV/tk plus GCV treatment appears to be highly selective in killing bladder cancer cell line in vitro.7 refs.2 tabs.
引用
收藏
页码:201 / 202
页数:2
相关论文
共 50 条
  • [41] A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model
    Higashi, Kosuke
    Hazama, Shoichi
    Araki, Atsuhiro
    Yoshimura, Kiyoshi
    Iizuka, Norio
    Yoshino, Shigefumi
    Noma, Takafumi
    Oka, Masaaki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (04) : 1412 - 1420
  • [42] Noninvasive theranostic imaging of HSV-TK/GCV suicide gene therapy in liver cancer by folate-targeted quantum dot-based liposomes
    Shao, Dan
    Li, Jing
    Pan, Yue
    Zhang, Xin
    Zheng, Xiao
    Wang, Zheng
    Zhang, Ming
    Zhang, Hong
    Chen, Li
    BIOMATERIALS SCIENCE, 2015, 3 (06) : 833 - 841
  • [43] Local inflammation and devascularization -: in vivo mechanisms of the "bystander effect" in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma
    Floeth, FW
    Shand, N
    Bojar, H
    Prisack, HB
    Felsberg, J
    Neuen-Jacob, E
    Aulich, A
    Burger, KJ
    Bock, WJ
    Weber, F
    CANCER GENE THERAPY, 2001, 8 (11) : 843 - 851
  • [44] Local inflammation and devascularization — in vivo mechanisms of the “bystander effect” in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma
    Frank W Floeth
    Nick Shand
    Hans Bojar
    Hans B Prisack
    Jörg Felsberg
    Eva Neuen-Jacob
    Albrecht Aulich
    Klaus J Burger
    Wolfgang J Bock
    Friedrich Weber
    Cancer Gene Therapy, 2001, 8 : 843 - 851
  • [45] Bystander effect-mediated gene therapy of experimental brain tumor by glioma cells carrying HSV-tk gene
    Tagawa, M
    Namba, H
    Iwadate, Y
    Miyagawa, T
    Sakiyama, S
    CANCER GENE THERAPY, 1997, 4 (06) : P119 - P119
  • [46] Selective elimination of long INterspersed element-1 expressing tumour cells by targeted expression of the HSV-TK suicide gene
    Chendeb, Mariam
    Schneider, Robert
    Davidson, Irwin
    Fadloun, Anas
    ONCOTARGET, 2017, 8 (24) : 38239 - 38250
  • [47] A novel Bifidobacterium infantis-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer
    Tang, Wei
    He, Yunfeng
    Zhou, Shengcai
    Ma, Yongping
    Liu, Geli
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009, 28
  • [48] A novel Bifidobacterium infantis-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer
    Wei Tang
    Yunfeng He
    Shengcai Zhou
    Yongping Ma
    Geli Liu
    Journal of Experimental & Clinical Cancer Research, 28
  • [49] Another mechanism causing the bystander effect besides the gap junction's role during the glioma gene therapy with HSV-TK/GCV system
    Du, LP
    Bai, SC
    Whittle, IR
    He, L
    GENE THERAPY OF CANCER, 1998, 451 : 133 - 138
  • [50] HSV-tk mediated suicide gene therapy leads to an immunogenic cell death of glioblastoma cells and a T-cell mediated immune response
    Hossain, J. A.
    Latif, A.
    Ninzima, S.
    Joseph, J. V.
    Ystaas, L. R.
    Blo, M.
    Riecken, K.
    Fehse, B.
    Bjerkvig, R.
    Miletic, H.
    HUMAN GENE THERAPY, 2018, 29 (12) : A49 - A49